Westford USA, Oct. 19, 2023 (GLOBE NEWSWIRE) -- The global Cholera Vaccines market size is expected to reach USD 191.13 billion by 2030 and exhibit a CAGR of 9.1% in the forecast period (2023−2030), according to Skyquest's latest research report. The growing aesthetic consciousness, increasing prevalence of obesity and overweight population, advancements in technology and treatment options, rising disposable incomes, expanding beauty and wellness industry, growing demand for non-invasive and minimally invasive procedures, the influence of social media and celebrity culture, improving safety and efficacy of Cholera Vaccines, rising focus on personal appearance and self-confidence, increasing awareness about the benefits of body contouring procedures is fueling the market's growth.
According to SkyQuest's latest global research of the Cholera Vaccines market, growing demand for non-surgical body contouring treatments, rise in combination therapies for enhanced results, increasing popularity of non-invasive fat reduction techniques, development of portable and home-use Cholera Vaccines, advancements in radiofrequency and ultrasound technologies, the emergence of cryolipolysis as a popular treatment modality, expanding market for Cholera Vaccines in emerging economies, integration of artificial intelligence and machine learning in body contouring technology, focus on personalized treatment plans and customization options, are the trends that aid in the market's growth.
Browse in-depth TOC on "Cholera Vaccines Market"
- Pages - 157
- Tables - 65
- Figures -79
Get sample copy of this report:
https://www.skyquestt.com/sample-request/cholera-vaccines-market
A cholera vaccine is a vaccine that can prevent cholera. It is made from killed or weakened cholera bacteria. The vaccine is given as an injection or as a liquid that is swallowed.
Prominent Players in Cholera Vaccines Market
- Acellent
- Aventis Pasteur
- Biological E.
- Bharat Biotech
- China National Biotics
- Emergent BioSolutions
- GSK
- IVAC
- Intercell
- Japan BCG
- SBL Vaccines
- Serum Institute of India
- Vabiotech
- Valneva
- Wyeth
- Wuhan Institute of Biological Products
- Zhifei Biological
- EuBiologics
- PaxVax
- VaxThera
- Vaxchora
Browse summary of the report and Complete Table of Contents (ToC):
https://www.skyquestt.com/report/cholera-vaccines-market
Report Scope & Segmentation:
| Attributes | Details |
| Forecast Period | 2023-2030 |
| Market Size in 2022 | 95.22 Billion |
| 2030 Value Projection | 191.13 Billion |
| CAGR | 9.1% |
| Segments Covered |
|
| Regions Covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Oral Cholera Vaccines (OCVs) Demand to Grow Substantially in the Forecast Period
Oral cholera vaccines (OCVs) dominated the global online market due to their ease of administration, effectiveness in providing immunity, and suitability for mass vaccination campaigns, especially in regions with limited healthcare infrastructure. The dominant OCV in the market has been Shanchol, followed by Dukoral.
Speak to Analyst for your custom requirements:
https://www.skyquestt.com/speak-with-analyst/cholera-vaccines-market
Travelers or Travel Vaccination are the Leading Application Segment
In terms of application, Travelers or Travel Vaccination are the leading segment due to the growth of international travel and tourism, more individuals are exposed to the risk of cholera when visiting countries with inadequate water and sanitation facilities.
South Asia Region is the leading Market Due to the Technological Advancements
Region-wise, South Asia Region is one of the largest growing markets due to the disease prevalence, healthcare infrastructure, government initiatives, and vaccination campaigns. However, historically, regions with a high incidence of cholera and limited access to clean water and sanitation have been more likely to dominate the market for cholera vaccines. The region has experienced recurrent cholera outbreaks due to inadequate water and sanitation facilities in many areas. Governments and international health organizations have been working to implement vaccination campaigns to control these outbreaks, leading to higher demand for cholera vaccines.
A recent report thoroughly analyzes the major players operating within the Cholera Vaccines market. This comprehensive evaluation has considered several crucial factors, such as collaborations, mergers, innovative business policies, and strategies, providing invaluable insights into the key trends and breakthroughs in the market. Additionally, the report has carefully scrutinized the market share of the top segments and presented a detailed geographic analysis. Finally, the report has highlighted the major players in the industry and their ongoing endeavours to develop innovative solutions that cater to the ever-increasing demand for Cholera Vaccines.
Key Developments in Cholera Vaccines Market
- Sanofi announced the launch of its first Digital Accelerator to foster its ambition to become a leading digital healthcare company.
Key Questions Answered in Cholera Vaccines Market Report
- What specific growth drivers will impact the market during the forecast period?
- Can you list the top companies in the market and explain how they have achieved their positions of influence?
- In what ways do regional trends and patterns differ within the global market, and how might these differences shape the market's future growth?
Related Reports in SkyQuest’s Library:
Global Cancer Supportive Care Drugs Market
Global Cold Blister Packaging Effective Choice Pharmaceutical Market
Global Liposomal Doxorubicin Market
Global Retinal Vein Occlusion Treatment Market
Global Mineral Supplements Market
About Us:
SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.
Address:
1 Apache Way, Westford, Massachusetts 01886
Phone:
USA (+1) 617-230-0741
Email: sales@skyquestt.com
